시장보고서
상품코드
1309678

세계의 세포 동결 배지 시장 규모, 점유율, 산업 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 전망 및 예측(2023-2030년)

Global Cell Freezing Media Market Size, Share & Industry Trends Analysis Report By Product (DMSO, Glycerol, and Others), By Application (Stem Cell lines, Cancer Cell Lines, and Others), By End-Use, By Regional Outlook and Forecast, 2023 - 2030

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 209 Pages | 배송안내 : 즉시배송


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포 동결 배지(Cell Freezing Media) 시장 규모는 2030년까지 2억 8,370만 달러에 달할 것으로 예상되며, 예측 기간 중 CAGR은 9.7%의 성장률로 상승할 것으로 예측되고 있습니다.

의료에서 가장 중요한 발전 중 하나는 줄기세포에서 나올 수 있습니다. 회복 의료의 발전에 큰 영향을 줄뿐만 아니라 줄기세포 연구는 인간 발달과 관련된 복잡한 과정에 대한 귀중한 통찰력을 제공합니다. 세포의 DNA는 줄기세포가 발달한 세포와 어떻게 다른지를 반영합니다. DNA는 전자 세포의 기능 유전자 내에서 부드럽게 조직화됩니다. 이 과정은 가역적이며, 유전자 서열 간의 상호작용이 이러한 다능성을 생성한다는 것은 잘 알려져 있습니다. 동결 세포의 회수율과 생존율은 보다 우수한 동결 배지 처방의 개발 등 동결보존법의 발전에 의해 개선되어 왔습니다. 얼음 결합 단백질로도 알려진 부동 단백질은 연구자가 생체 모방 재료로 복제를 시도한 단백질 중 하나입니다. 수많은 연구 기관과 바이오 의약품 제조업체가 바로 사용할 수 있는 동결 배지를 채용한 것은 연구 업무에서 실용적인 해결책을 신속하게 제공하는 것이 요구된 결과입니다.

COVID-19 팬데믹은 시장에 유익한 영향을 미쳤습니다. 백신의 제조에는 실험실 간의 이송을 포함한 많은 처리 단계가 있기 때문에 동결보존이 필수적이었습니다. 수많은 연구 기관이나 바이오 의약품 제조업체가 바로 사용할 수 있는 동결 배지를 채용했습니다. 게다가 연구개발산업에서는 제휴, 확대, 공동연구에 대한 투자가 증가하고 있으며, 이것이 시장 확대의 원동력이 되고 있습니다.

그러나, 동결 후 세포의 회수율은 기존의 동결보존 기술의 주요 단점 중 하나입니다. 회수율이 높기 때문에 연구자는 연구 프로젝트에 임할 때, 세포가 증식하기를 기다려야 하고, 임상 응용에는 불가능할지도 모릅니다. 그러나 동결보호제인 DMSO는 양에 따라 세포에 해롭고 동결보호제의 단점 중 하나가 되고 있습니다. 따라서 이러한 요소는 향후 수년간 시장 성장을 방해할 수 있습니다.

제품 전망

제품은 DMSO, 글리세롤 등으로 분류됩니다. 글리세롤 부문은 2022년 시장에서 상당한 성장률을 확보했습니다. 글리세롤은 비전해질이므로, 임의의 특정 온도에서 셀 주위 또는 내부에 남아 있는 미동결 용액의 전해질 농도를 낮추는 것으로 작동할 수 있습니다. 박테리아와 동물의 정자 보존에 자주 사용됩니다. 주요 제조 업체는 또한 시장에서 다양한 CPA 농도 수요에 맞게 세포 동결 배지의 제공을 조정하고 있습니다. 그 결과, 소비자의 밑단을 넓히고 종합적인 조사를 실시할 수 있어, 둘 다 더 많은 수입을 얻는데 도움이 됩니다.

용도별 전망

용도별로 시장은 줄기세포주, 암세포주 등으로 분류됩니다. 줄기세포주 부문은 2022년 시장에서 가장 큰 수익 점유율을 얻었습니다. 유전자 치료 및 세포 치료와 같은 효과적인 치료법 및 승인 증가로 이어지는 기술 혁신의 활성화로 인해 바이오 의약품에 대한 요구가 높아지고 있습니다. 이들이 이 분야 상승의 주요 원동력이 되고 있습니다. 앞으로 수년간 미국 FDA는 기존의 임상 성공률과 제품 파이프라인의 결과로 매년 많은 세포 및 유전자 치료 제품을 승인할 것으로 예상됩니다. 예상 수요가 증가함에 따라 시장 관계자는 모든 소모품에 대해 효과적인 공급망을 수립해야 합니다.

최종 용도별 전망

최종 용도별로, 시장은 제약·바이오테크놀로지 기업, 연구 및 학술기관, 기타로 나눌 수 있습니다. 연구 및 학술기관 부문은 2022년 시장에서 현저한 성장률을 획득했습니다. 이 분야의 급성장은 예측기간 동안 연구개발 노력 증가로 인한 것입니다. COVID-19의 발달로 산업 전문가들은 현행 기술의 지속적인 연구와 개발의 필요성을 더욱 강하게 인식하고 있습니다. 연구기관과의 제휴와 팀워크에 대한 막대한 투자가 예상되는 성장에 기여하고 있습니다.

지역별 전망

지역별로 볼 때 시장은 북미, 유럽, 아시아 태평양, LAMEA로 분석됩니다. 북미 부문은 2022년 시장에서 가장 높은 수익 점유율을 획득했습니다. 신흥 경제 국가, 대기업, 확립된 공급 채널의 존재는 시장 전체의 성장에 기여하고 있습니다. 바이오의약품산업을 통해 최첨단의 효과적인 치료법을 만들어내려는 움직임은 질병의 빈발과 노인 증가에도 뒷받침되고 있습니다. 이것은 세포 동결 배지의 필요에 불을 붙이고 앞으로도 계속 될 것으로 예상됩니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 개요

  • 소개
    • 개요
      • 시장 구성 및 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 성장 촉진 요인
    • 시장 성장 억제 요인

제3장 세포 동결 배지 시장에서 전개되고 있는 전략

제4장 세계의 세포 동결 배지 시장 : 제품별

  • 세계의 DMSO 시장 : 지역별
  • 세계의 글리세롤 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제5장 세계의 세포 동결 배지 시장 : 용도별

  • 세계의 줄기세포주 시장 : 지역별
  • 세계의 암세포주 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제6장 세계의 세포 동결 배지 시장 : 최종 용도별

  • 세계의 제약·바이오테크놀로지 기업 시장 : 지역별
  • 세계의 연구 및 학술기관 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제7장 세계의 세포 동결 배지 시장 : 지역별

  • 북미
    • 북미 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미
  • 유럽
    • 유럽 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽
  • 아시아 태평양
    • 아시아 태평양 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아 태평양
  • 남미·중동·아프리카
    • 남미·중동·아프리카 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트(UAE)
      • 사우디아라비아
      • 남아프리카
      • 나이지리아
      • 기타 남미·중동·아프리카

제8장 기업 개요

  • Thermo Fisher Scientific, Inc
  • Merck KGaA
  • Sartorius AG
  • Bio-Techne Corporation
  • HiMedia Laboratories Pvt Ltd.
  • BPS Bioscience, Inc
  • BioLife Solutions, Inc
  • PromoCell GmbH
  • Capricorn Scientific GmbH
  • Cell Applications, Inc
LYJ 23.08.22

The Global Cell Freezing Media Market size is expected to reach $283.7 million by 2030, rising at a market growth of 9.7% CAGR during the forecast period.

Pharmaceutical & Biotechnological Companies are the major end users of cell freezing media for development of biologics, toxicological testing, and drug discovery. Consequently, the pharmaceutical & biopharmaceutical sector would capture more than 45% share of the market by 2030. According to the US Congressional Budget Office, the pharmaceutical sector spent $83 billion on research and development in 2019. These costs were incurred for various activities, including developing and testing novel medications, incremental innovation of product expansions, and clinical testing for marketing or safety monitoring.

Similarly, the pharmaceuticals and biotechnology sector produced goods valued at more than S$16 billion for export in 2016, according to the Singapore Economic Development Board (EDB), a government organization under the Ministry of Trade and Industry. Some of the factors impacting the market are increasing study of cell-based therapies, new developments in cryopreservation technology, and issues with the usage of common cell freezing media.

One of the most significant developments in medicine could come from stem cells. In addition to significantly impacting the development of restorative medicine, their research provides valuable insight into the intricate processes involved in human development. The DNA of the cells reflects how a stem cell differs from a developed cell. DNA is loosely organized in the former cell's functional genes. This process is reversible, and it is well known that interactions between gene sequences can produce such pluripotency. Frozen cells' recovery rates and viability have been improved because of ongoing developments in cryopreservation methods, such as creating better-freezing media formulations. The antifreeze protein, also known as an ice-binding protein, is one of the proteins researchers have attempted to duplicate with biomimetic materials. Numerous research institutes, as well as biopharmaceutical manufacturers, adopted the ready-to-use freezing media as a result of the demand for quicker turnaround times with practical solutions from research operations.

The COVID-19 pandemic had a beneficial effect on the market. For the creation of vaccines, cryopreservation was essential because there were numerous processing phases, including transfer between laboratories. Numerous research institutes, as well as biopharmaceutical manufacturers, adopted the ready-to-use freezing media as a result of the demand for quicker turnaround times with practical solutions from research operations. Additionally, the R&D industry saw increasing investments in partnerships, expansion, and collaboration, which fueled market expansion.

However, the rate of recovery of cells following freezing is one of the key drawbacks of existing cryopreservation techniques. Because of high recovery rates, researchers must wait for the cells to multiply when working on a research project, which might not be possible for clinical applications. However, the cryoprotectant, DMSO, is harmful to cells in some quantities, making it one of the downsides of cryoprotectants. which might be problematic. Hence, these elements can hamper the market's growth in the coming years.

Product Outlook

Based on product, the market is characterized into DMSO, glycerol, and others. The glycerol segment procured a considerable growth rate in the market in 2022. Due to its non-electrolyte nature, glycerol has the potential to function by lowering the electrolyte concentration of the remaining unfrozen solution around and in a cell at any particular temperature. It is frequently utilized to store germs and animal sperm. The major producers are also coordinating their cell freezing media offerings with the demand for varying CPA concentrations in the market. As a result, they can broaden their consumer base and conduct inclusive research, both of which will help them generate more income.

Application Outlook

On the basis of application, the market is classified into stem cell lines, cancer cell lines, and others. The stem cell lines segment acquired the largest revenue share in the market in 2022. The need for biopharmaceuticals is increasing due to effective therapies like gene and cell therapy and an uptick in innovation that has led to an increase in approvals. These are the main driving forces behind the segment's rise. In the coming years, the U.S. FDA is anticipated to approve many more cell and gene therapy products annually as a result of the existing clinical success rates as well as the product pipeline. The anticipated rise in demand has prompted market players to establish an effective supply chain for all consumables.

End-use Outlook

By end-use, the market is divided into pharmaceutical & biotechnological companies, research & academic institutes, and others. The research and academic institutes segment garnered a remarkable growth rate in the market in 2022. The rapid expansion of the segment can be attributed to an increase in R&D efforts during the predicted period. The COVID-19 outbreak made industry experts more conscious of the need for ongoing study and development of current technologies. Huge investments in alliances and teamwork with research institutes contribute to the anticipated growth.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The existence of developed economies, significant players, and well-established supply channels all contribute to the market's overall growth. The rush to produce cutting-edge and effective treatments through the biopharmaceutical industry has also been fueled by the frequency of diseases and the rise in seniors. This has sparked a need for cell freezing media and is anticipated to continue in the future.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Bio-Techne Corporation, HiMedia Laboratories Pvt. Ltd., BPS Bioscience, Inc., BioLife Solutions, Inc., PromoCell GmbH, Capricorn Scientific GmbH, and Cell Applications, Inc.

Scope of the Study

Market Segments covered in the Report:

By Product

  • DMSO
  • Glycerol
  • Others

By Application

  • Stem Cell lines
  • Cancer Cell Lines
  • Others

By End-Use

  • Pharmaceutical & Biotechnological Companies
  • Research & Academic Institutes
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Sartorius AG
  • Bio-Techne Corporation
  • HiMedia Laboratories Pvt. Ltd.
  • BPS Bioscience, Inc.
  • BioLife Solutions, Inc.
  • PromoCell GmbH
  • Capricorn Scientific GmbH
  • Cell Applications, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cell Freezing Media Market, by Product
    • 1.4.2 Global Cell Freezing Media Market, by Application
    • 1.4.3 Global Cell Freezing Media Market, by End-Use
    • 1.4.4 Global Cell Freezing Media Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Cell Freezing Media Market

Chapter 4. Global Cell Freezing Media Market by Product

  • 4.1 Global DMSO Market by Region
  • 4.2 Global Glycerol Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Cell Freezing Media Market by Application

  • 5.1 Global Stem Cell lines Market by Region
  • 5.2 Global Cancer Cell Lines Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Cell Freezing Media Market by End-use

  • 6.1 Global Pharmaceutical & Biotechnological Companies Market by Region
  • 6.2 Global Research & Academic Institutes Market by Region
  • 6.3 Global Others Market by Region

Chapter 7. Global Cell Freezing Media Market by Region

  • 7.1 North America Cell Freezing Media Market
    • 7.1.1 North America Cell Freezing Media Market by Product
      • 7.1.1.1 North America DMSO Market by Country
      • 7.1.1.2 North America Glycerol Market by Country
      • 7.1.1.3 North America Others Market by Country
    • 7.1.2 North America Cell Freezing Media Market by Application
      • 7.1.2.1 North America Stem Cell lines Market by Country
      • 7.1.2.2 North America Cancer Cell Lines Market by Country
      • 7.1.2.3 North America Others Market by Country
    • 7.1.3 North America Cell Freezing Media Market by End-use
      • 7.1.3.1 North America Pharmaceutical & Biotechnological Companies Market by Country
      • 7.1.3.2 North America Research & Academic Institutes Market by Country
      • 7.1.3.3 North America Others Market by Country
    • 7.1.4 North America Cell Freezing Media Market by Country
      • 7.1.4.1 US Cell Freezing Media Market
        • 7.1.4.1.1 US Cell Freezing Media Market by Product
        • 7.1.4.1.2 US Cell Freezing Media Market by Application
        • 7.1.4.1.3 US Cell Freezing Media Market by End-use
      • 7.1.4.2 Canada Cell Freezing Media Market
        • 7.1.4.2.1 Canada Cell Freezing Media Market by Product
        • 7.1.4.2.2 Canada Cell Freezing Media Market by Application
        • 7.1.4.2.3 Canada Cell Freezing Media Market by End-use
      • 7.1.4.3 Mexico Cell Freezing Media Market
        • 7.1.4.3.1 Mexico Cell Freezing Media Market by Product
        • 7.1.4.3.2 Mexico Cell Freezing Media Market by Application
        • 7.1.4.3.3 Mexico Cell Freezing Media Market by End-use
      • 7.1.4.4 Rest of North America Cell Freezing Media Market
        • 7.1.4.4.1 Rest of North America Cell Freezing Media Market by Product
        • 7.1.4.4.2 Rest of North America Cell Freezing Media Market by Application
        • 7.1.4.4.3 Rest of North America Cell Freezing Media Market by End-use
  • 7.2 Europe Cell Freezing Media Market
    • 7.2.1 Europe Cell Freezing Media Market by Product
      • 7.2.1.1 Europe DMSO Market by Country
      • 7.2.1.2 Europe Glycerol Market by Country
      • 7.2.1.3 Europe Others Market by Country
    • 7.2.2 Europe Cell Freezing Media Market by Application
      • 7.2.2.1 Europe Stem Cell lines Market by Country
      • 7.2.2.2 Europe Cancer Cell Lines Market by Country
      • 7.2.2.3 Europe Others Market by Country
    • 7.2.3 Europe Cell Freezing Media Market by End-use
      • 7.2.3.1 Europe Pharmaceutical & Biotechnological Companies Market by Country
      • 7.2.3.2 Europe Research & Academic Institutes Market by Country
      • 7.2.3.3 Europe Others Market by Country
    • 7.2.4 Europe Cell Freezing Media Market by Country
      • 7.2.4.1 Germany Cell Freezing Media Market
        • 7.2.4.1.1 Germany Cell Freezing Media Market by Product
        • 7.2.4.1.2 Germany Cell Freezing Media Market by Application
        • 7.2.4.1.3 Germany Cell Freezing Media Market by End-use
      • 7.2.4.2 UK Cell Freezing Media Market
        • 7.2.4.2.1 UK Cell Freezing Media Market by Product
        • 7.2.4.2.2 UK Cell Freezing Media Market by Application
        • 7.2.4.2.3 UK Cell Freezing Media Market by End-use
      • 7.2.4.3 France Cell Freezing Media Market
        • 7.2.4.3.1 France Cell Freezing Media Market by Product
        • 7.2.4.3.2 France Cell Freezing Media Market by Application
        • 7.2.4.3.3 France Cell Freezing Media Market by End-use
      • 7.2.4.4 Russia Cell Freezing Media Market
        • 7.2.4.4.1 Russia Cell Freezing Media Market by Product
        • 7.2.4.4.2 Russia Cell Freezing Media Market by Application
        • 7.2.4.4.3 Russia Cell Freezing Media Market by End-use
      • 7.2.4.5 Spain Cell Freezing Media Market
        • 7.2.4.5.1 Spain Cell Freezing Media Market by Product
        • 7.2.4.5.2 Spain Cell Freezing Media Market by Application
        • 7.2.4.5.3 Spain Cell Freezing Media Market by End-use
      • 7.2.4.6 Italy Cell Freezing Media Market
        • 7.2.4.6.1 Italy Cell Freezing Media Market by Product
        • 7.2.4.6.2 Italy Cell Freezing Media Market by Application
        • 7.2.4.6.3 Italy Cell Freezing Media Market by End-use
      • 7.2.4.7 Rest of Europe Cell Freezing Media Market
        • 7.2.4.7.1 Rest of Europe Cell Freezing Media Market by Product
        • 7.2.4.7.2 Rest of Europe Cell Freezing Media Market by Application
        • 7.2.4.7.3 Rest of Europe Cell Freezing Media Market by End-use
  • 7.3 Asia Pacific Cell Freezing Media Market
    • 7.3.1 Asia Pacific Cell Freezing Media Market by Product
      • 7.3.1.1 Asia Pacific DMSO Market by Country
      • 7.3.1.2 Asia Pacific Glycerol Market by Country
      • 7.3.1.3 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Cell Freezing Media Market by Application
      • 7.3.2.1 Asia Pacific Stem Cell lines Market by Country
      • 7.3.2.2 Asia Pacific Cancer Cell Lines Market by Country
      • 7.3.2.3 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Cell Freezing Media Market by End-use
      • 7.3.3.1 Asia Pacific Pharmaceutical & Biotechnological Companies Market by Country
      • 7.3.3.2 Asia Pacific Research & Academic Institutes Market by Country
      • 7.3.3.3 Asia Pacific Others Market by Country
    • 7.3.4 Asia Pacific Cell Freezing Media Market by Country
      • 7.3.4.1 China Cell Freezing Media Market
        • 7.3.4.1.1 China Cell Freezing Media Market by Product
        • 7.3.4.1.2 China Cell Freezing Media Market by Application
        • 7.3.4.1.3 China Cell Freezing Media Market by End-use
      • 7.3.4.2 Japan Cell Freezing Media Market
        • 7.3.4.2.1 Japan Cell Freezing Media Market by Product
        • 7.3.4.2.2 Japan Cell Freezing Media Market by Application
        • 7.3.4.2.3 Japan Cell Freezing Media Market by End-use
      • 7.3.4.3 India Cell Freezing Media Market
        • 7.3.4.3.1 India Cell Freezing Media Market by Product
        • 7.3.4.3.2 India Cell Freezing Media Market by Application
        • 7.3.4.3.3 India Cell Freezing Media Market by End-use
      • 7.3.4.4 South Korea Cell Freezing Media Market
        • 7.3.4.4.1 South Korea Cell Freezing Media Market by Product
        • 7.3.4.4.2 South Korea Cell Freezing Media Market by Application
        • 7.3.4.4.3 South Korea Cell Freezing Media Market by End-use
      • 7.3.4.5 Singapore Cell Freezing Media Market
        • 7.3.4.5.1 Singapore Cell Freezing Media Market by Product
        • 7.3.4.5.2 Singapore Cell Freezing Media Market by Application
        • 7.3.4.5.3 Singapore Cell Freezing Media Market by End-use
      • 7.3.4.6 Malaysia Cell Freezing Media Market
        • 7.3.4.6.1 Malaysia Cell Freezing Media Market by Product
        • 7.3.4.6.2 Malaysia Cell Freezing Media Market by Application
        • 7.3.4.6.3 Malaysia Cell Freezing Media Market by End-use
      • 7.3.4.7 Rest of Asia Pacific Cell Freezing Media Market
        • 7.3.4.7.1 Rest of Asia Pacific Cell Freezing Media Market by Product
        • 7.3.4.7.2 Rest of Asia Pacific Cell Freezing Media Market by Application
        • 7.3.4.7.3 Rest of Asia Pacific Cell Freezing Media Market by End-use
  • 7.4 LAMEA Cell Freezing Media Market
    • 7.4.1 LAMEA Cell Freezing Media Market by Product
      • 7.4.1.1 LAMEA DMSO Market by Country
      • 7.4.1.2 LAMEA Glycerol Market by Country
      • 7.4.1.3 LAMEA Others Market by Country
    • 7.4.2 LAMEA Cell Freezing Media Market by Application
      • 7.4.2.1 LAMEA Stem Cell lines Market by Country
      • 7.4.2.2 LAMEA Cancer Cell Lines Market by Country
      • 7.4.2.3 LAMEA Others Market by Country
    • 7.4.3 LAMEA Cell Freezing Media Market by End-use
      • 7.4.3.1 LAMEA Pharmaceutical & Biotechnological Companies Market by Country
      • 7.4.3.2 LAMEA Research & Academic Institutes Market by Country
      • 7.4.3.3 LAMEA Others Market by Country
    • 7.4.4 LAMEA Cell Freezing Media Market by Country
      • 7.4.4.1 Brazil Cell Freezing Media Market
        • 7.4.4.1.1 Brazil Cell Freezing Media Market by Product
        • 7.4.4.1.2 Brazil Cell Freezing Media Market by Application
        • 7.4.4.1.3 Brazil Cell Freezing Media Market by End-use
      • 7.4.4.2 Argentina Cell Freezing Media Market
        • 7.4.4.2.1 Argentina Cell Freezing Media Market by Product
        • 7.4.4.2.2 Argentina Cell Freezing Media Market by Application
        • 7.4.4.2.3 Argentina Cell Freezing Media Market by End-use
      • 7.4.4.3 UAE Cell Freezing Media Market
        • 7.4.4.3.1 UAE Cell Freezing Media Market by Product
        • 7.4.4.3.2 UAE Cell Freezing Media Market by Application
        • 7.4.4.3.3 UAE Cell Freezing Media Market by End-use
      • 7.4.4.4 Saudi Arabia Cell Freezing Media Market
        • 7.4.4.4.1 Saudi Arabia Cell Freezing Media Market by Product
        • 7.4.4.4.2 Saudi Arabia Cell Freezing Media Market by Application
        • 7.4.4.4.3 Saudi Arabia Cell Freezing Media Market by End-use
      • 7.4.4.5 South Africa Cell Freezing Media Market
        • 7.4.4.5.1 South Africa Cell Freezing Media Market by Product
        • 7.4.4.5.2 South Africa Cell Freezing Media Market by Application
        • 7.4.4.5.3 South Africa Cell Freezing Media Market by End-use
      • 7.4.4.6 Nigeria Cell Freezing Media Market
        • 7.4.4.6.1 Nigeria Cell Freezing Media Market by Product
        • 7.4.4.6.2 Nigeria Cell Freezing Media Market by Application
        • 7.4.4.6.3 Nigeria Cell Freezing Media Market by End-use
      • 7.4.4.7 Rest of LAMEA Cell Freezing Media Market
        • 7.4.4.7.1 Rest of LAMEA Cell Freezing Media Market by Product
        • 7.4.4.7.2 Rest of LAMEA Cell Freezing Media Market by Application
        • 7.4.4.7.3 Rest of LAMEA Cell Freezing Media Market by End-use

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Product Launches and Product Expansions:
      • 8.1.5.2 Acquisition and Mergers:
    • 8.1.6 SWOT Analysis
  • 8.2 Merck KGaA
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Acquisition and Mergers:
  • 8.3 Sartorius AG
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Bio-Techne Corporation
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
  • 8.5 HiMedia Laboratories Pvt. Ltd.
    • 8.5.1 Company Overview
  • 8.6 BPS Bioscience, Inc.
    • 8.6.1 Company Overview
  • 8.7 BioLife Solutions, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expenses
  • 8.8 PromoCell GmbH
    • 8.8.1 Company Overview
  • 8.9 Capricorn Scientific GmbH
    • 8.9.1 Company Overview
  • 8.10. Cell Applications, Inc.
    • 8.10.1 Company Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제